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Abstract
Background: Cervical and ocular vestibular evoked myogenic potentials (c/oVEMPs) reflect otolith function.
Up-to-date, there are no published reports on the systemic evaluation of otolith function in Ménière’s Disease (MD)
nor are there any reports on the differences in VEMPs between patients with early and late stage MD. The aim of
this study was to evaluate the difference in c/oVEMPs between patients with MD and normal controls, as well as
between patients with early and late stage MD.
Methods: Thirty patients with unilateral MD and thirty healthy subjects (as normal controls) were prospectively
enrolled. c/oVEMPs using 500 Hz tone-burst stimuli were performed. VEMP tests were repeated 3 times on each
subject to ensure reliability and reproducibility of responses. VEMPs were defined as present or absent. Abnormal
VEMP was defined by lack of VEMP response.
Results: In the control group, abnormal cVEMPs and oVEMPs responses were detected in 6.67 and 3.34 %
respectively. In MD patients (20 with early stage MD [ES-MD], 10 with late stage MD [LS-MD]), abnormal cVEMPs
and oVEMPs responses were detected in 40 and 16.7 % respectively. More patients with MD showed abnormal
responses in c/oVEMPs as compared to the control group (p < 0.05). cVEMPs was more often abnormal as
compared to oVEMPs in MD patients (p < 0.05). There was a significant difference in abnormal cVEMP responses
between ES-MD patients (25 %) and LS-MD patients (70 %) (p < 0.05). Difference in abnormal oVEMP responses
(ES-MD, 5 %; LS-MD, 40 %) was significant (p < 0.05).
Conclusion: An increased occurrence of abnormal c/oVEMP recordings appeared in MD patients, possibly as a
result of hydrops of the otolith. cVEMPs were more often abnormal in MD patients as compared to oVEMPs,
suggesting that saccular dysfunction may be more common than utricular dysfunction. Furthermore, o/cVEMP
abnormalities in the LS-MD group were significantly higher than those in the ES-MD group, suggesting the trend
that otolith damage is gradually increasing with the aggravation of cochlear injury in MD.
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Background
By stimulating the ear with air-conducted sound (ACS)
or bone-conducted vibration (BCV) stimuli, vestibular-
evoked myogenic potential (VEMP) can be recorded on
the contracted neck muscles, so-called cervical VEMP
(cVEMP), and on the extraocular muscles, termed ocular
VEMP (oVEMP). In 1992 and 1994, cVEMPs was first
described by Colebatch and Halmagyi [1, 2], who mea-
sured electromyographic (EMG) activity from the
sternocleidomastoid (SCM) muscles following vestibular
stimulation with clicks. In 1995, Halmagyi et al. [3] elic-
ited cVEMPs by tapping the forehead. The responses
had the same biphasic waveform as the AC cVEMPs and
were vestibular-dependent. In 2000, Sheykholeslami et
al. [4] recorded cVEMPs using BC sound delivered to
the mastoid bone with a clinical bone conductor. In
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2005 and 2007, Rosengren [5] and Todd [6] recorded
the short latency potentials from around the eyes and
demonstrated that it can also be recorded from the
extraocular muscles. It was recently reported that ocular
VEMPs (oVEMPs) are produced by synchronous activity
in the extraocular muscles in response to stimulation,
including sound [7]. A more recent study reported that
oVEMPs in response to air-conducted sound (ACS) re-
flect functions of different parts of the vestibular laby-
rinth from cVEMPs in response to ACS; that is,
oVEMPs predominantly reflect utricular functions while
cVEMPs reflect saccular functions [8].
Prosper Ménière described MD in 1861, but a diagnos-
tic test with high specificity and sensitivity still has not
been developed. Furthermore, even the histological find-
ings are not directly related to the symptoms and clinical
course [9]. Clinicians make a diagnosis based on the
symptoms and the results of a hearing test. In 1995, the
American Academy of Otolaryngology-Head and Neck
Surgery (AAO-HNS) proposed diagnostic criteria for
MD and a staging system based on hearing function
measured by pure tone threshold at 0.5, 1.0, 2.0, and
3.0 kHz [10]. Patients with MD present fluctuating hear-
ing and vertigo. Therefore, it is important to identify ir-
reversible damage among the fluctuating symptoms.
Currently, irreversible damage from MD is measured
solely on the basis of hearing impairment. However in
the conventional staging system, intact vestibular func-
tion is usually evident in later stage MD [11]. One pos-
sible hypothesis is that the caloric test does not reflect
vestibular loss in MD [12]. A vestibular function test that
reflects functional loss in MD is clearly required. Be-
cause the otolith is anatomically close to the cochlea,
there is a possibility that its functional loss may occur
just after the cochlear functional loss. Okuno et al. [13]
reported on the incidence of endolymphatic hydrops in
each department of the labyrinth. Twenty-two temporal
bones from deceased patients with MD were examined.
The authors reported cochlear hydrops in all temporal
bones; 86.5 % had saccular hydrops, 50 % had utricular
hydrops and 36.4 % had hydrops in the semicircular
canal [14].
Based on this pathological background, VEMP can be
used as a test of the otolith organ and peripheral ves-
tibular function [2]. Several studies have investigated the
correlation of VEMP with hearing impairment in MD.
Young et al. [15] defined the interaural amplitude differ-
ence (IAD) ratio in 40 patients, and reported a correl-
ation of the IAD ratio of VEMPs with the conventional
stage of MD. De Waele et al. [12] reported that saccular
impairment correlates with low-frequency hearing loss.
However, other studies did not report a significant dif-
ference in VEMPs from MD patients compared to nor-
mal subjects [16, 17]. Thus, the clinical role of VEMP in
MD remains debatable. Furthermore, the systemic evalu-
ation of otolith damage in MD patients has never been
reported. Up to date, there are no reports on the differ-
ences in VEMPs between early stage MD (ES-MD) pa-
tients (I, II, III stage) and late stage MD (LS-MD)
patients (IV stage). The aim of this study is to determine
the diagnostic value of VEMP in MD by evaluating the
difference in c/oVEMPs between patients with MD and
controls, as well as between patients with ES-MD and
LS-MD. Through this analysis, we tried to confirm the
role of VEMP as a new evaluation test.
Methods
Subjects
Ethical approval was received from the Ethics Com-
mittee of Affiliated Yantai Yuhuangding Hospital of
Qingdao University Medical College. Between January
2013 and January 2015, 30 consecutive patients with
definite unilateral Menière’s disease were prospectively
enrolled from the Dizziness Clinic of Affiliated Yantai
Yuhuangding Hospital of Qingdao University Medical
College. Audiometric evaluation was performed at
frequencies of 500, 1000, 2000 and 3000 Hz, and pa-
tients were grouped according to AAO-HNS guide-
lines: stage I, 0–25 dB hearing level (HL); stage II, 25–
40 dB HL; stage III, 41–70 dB HL, and stage IV worse
than 70 dB HL. Patients were divided into two groups ac-
cording to the stage- 20 early stage patients (ES-MD
group, I, II, III stage) and 10 late stage (LS-MD group, IV
stage). The diagnosis and periodization of MD patients
was according to the criteria for definite MD recom-
mended in 1995 by the AAO-HNS Committee on Hearing
and Equilibrium [10].
Patients who underwent endolymphatic sac surgery or
who were treated with an intratympanic injection of
gentamicin before enrollment were excluded from the
analysis. In addition, patients with a history of a brain
tumor or vestibular schwannoma, or any neurological,
psychiatric, or significant medical disease were excluded.
The control subjects were all volunteers from our nor-
mal outpatient clinic who had no otological disease. Pa-
tients with a history of hearing loss, other vestibular
disorders and >60 years old were excluded. Informed
consent was obtained from each subject according to
the Declaration of Helsinki.
cVEMPs
Cervical vestibular evoked myogenic potentials (cVEMPs)
testing was performed on both sides for all patients and
controls. In the cVEMPs test, all subjects were placed in a
sitting position and asked to rotate their head away from
the stimulated side so as to record electromyographic ac-
tivity over tonically activated sternocleidomastoid (SCM)
muscles. Surface EMG activity was recorded with
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superficial electrodes placed on the middle third of the
SCM, with the reference electrode placed on the upper
third of the sternum and the ground electrode on the mid-
dle of the forehead. Using a Bio-Logic Navigator Pro, 90
dBnHL 500 Hz tone bursts were presented through head-
phones, and the EMG signal was amplified and bandpass
filtered (30–1500 Hz). The analysis window was 100 ms
wide and responses to 120 stimuli were averaged. cVEMP
tests were repeated 3 times on each subject to ensure reli-
ability and reproducibility of responses. The amplitude of
the first positive–negative peak (P13–N23) was recorded.
Absence of a meaningful wave form with p13 and n23 was
defined as ‘no response’. Abnormality was strictly defined
as a cVEMP pattern of ‘no response’.
oVEMPs
Ocular vestibular evoked myogenic potentials (oVEMPs)
testing was performed on both sides for all patients and
controls. In the oVEMPs test, all subjects assumed a sit-
ting position and the subject was instructed to look
superomedially at a small fixed target 1 m from the eyes.
The visual angle was approximately 30°, which has been
found to elicit the largest responses compared with
other eye positions [18]. The active electrodes were
placed on the face, oriented vertically and approximately
1 cm below the center of the lower eyelid just inferior to
the contralateral eye for sound stimulation. The refer-
ence electrode was placed about 1 cm below the active
electrode on the cheek, and the ground electrode was
placed on the forehead. Each subject’s eyes remained
fixed on the target throughout the test. Using a Bio-
Logic Navigator Pro, 95 dBnHL 500 Hz tone bursts were
presented through headphones, and the EMG signal was
amplified and bandpass filtered (10–300 Hz). The ana-
lysis window was 100 ms wide and responses to 120
stimuli were averaged. oVEMP tests were repeated 3
times on each subject to ensure reliability and reprodu-
cibility of responses. The initial negative–positive bi-
phasic waveform comprised peaks N1 and P1. We
analyzed the waveforms of N1 and P1 at the maximal in-
tensity of stimulation. Abnormality was strictly defined
as an oVEMP pattern of ‘no response’.
Statistical analysis
A Fishers exact or Chi-squared test was used to analyze
the statistical significance of the inter-group difference
in the number of non- cVEMPs and oVEMPs responders
in the MD and controls groups. A p value of < 0.05 indi-
cated statistical significance.
Results
The ages ranged from 35 to 54 years (mean 45 years, 12
men and 18 women) in patients with MD. The control
group consisted of 30 normal subjects (10 men and 20
women; mean age 40 years; age range, 30–60 years). The
Pure-Tone-Average (PTA) of ES-MD and LS-MD
groups were 45 and 80 dBnHL respectively. Demo-
graphic data for MD and control groups are summarized
in Table 1. There were no significant differences in age
and sex ratio between the two groups (p > 0.05). Testing
of VEMPs was performed on both sides in all MD pa-
tients and controls. No patient with MD showed bilat-
eral abnormalities, so only ipsilesional data are
presented. In the control group, abnormal cVEMP re-
sponses were detected in 2 of 30 (6.67 %) subjects and
abnormal oVEMP responses were detected in 1 of 30
(3.34 %) subjects (Table 2).
cVEMP abnormalities in MD patients
Abnormal cVEMP responses were detected in 12 of 30
(40 %) MD subjects. More patients with MD showed ab-
normal responses in cVEMPs as compared to the con-
trols (p < 0.05). In cVEMPs testing, abnormalities were
detected in 5 of 20 (25 %) in the ES-MD group and in 7
of 10 (70 %) subjects in the LS-MD group; the difference
between the two groups was significant (p < 0.05)
(Table 2).
oVEMP abnormalities in MD patients
Abnormal oVEMP responses were detected in 5 of 30
(16.7 %) subjects in MD group. More patients with MD
showed abnormal responses in oVEMPs as compared to
the controls (p < 0.05). In oVEMPs testing, abnormalities
were detected in 1 of 20 (5 %) in the ES-MD group and
in 4 of 10 (40 %) subjects in the LS-MD group; the
difference between the two groups was significant (p <
0.05) (Table 2).
Comparison of cVEMPs with oVEMPs in MD patients
Abnormal cVMEPs responses were detected in 12 of 30
(40 %) subjects in MD group while abnormal oVMEPs
responses were detected in 5 of 30 (16.7 %). The abnor-
mal results for cVEMPs showed a higher percentage
than those for oVEMPs in MD patients (p < 0.05)
(Table 2).






Number 30 20 10
Age*(M ± SD) 40 ± 8.0 42 ± 6.0 47 ± 7.0
Sex(M:F)* 10:20 8:12 4:6
PTA(M ± SD) Normal 45 ± 6.5 80 ± 4.0
MD Ménière’s disease. *p > 0.05. ES early stage group in MD, LS late stage
group in MD, PTA pure-tone-average
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Discussion
The main objective in this study was to report c/oVEMPs
findings in MD patients and to verify some clinical charac-
teristics of MD in VEMPs. We evaluated the function of
otolith by measuring c/oVEMPs. At present, cVEMPs
which are evoked by air-conducted sound (ACS), are
widely used to evaluate the function of saccule and infer-
ior vestibular nerve by recording the inhibitory potential
from the SCM. Curthoys et al. [7] and Shin et al. [19] re-
ported that the oVEMP evoked by ACS may be predomin-
antly mediated by the superior vestibular nerve due to the
activation of the utricular receptors. Ménière’s disease
(MD) is an idiopathic syndrome characterized by recur-
rent vertigo, hearing loss, ear fullness and tinnitus [18]. Its
pathological basis is hydrops and dilatation of the endo-
lymphatic spaces involved in both hearing and balance.
Endolymphatic hydrops leads to distortion of the
membranous labyrinth or rupture of Reissener’s mem-
brane [13, 20]. Hydrops occurs most often in the
cochlea, with the otolith as the second most frequent
site for endolymphatic hydrops [21]. The hydrops
process at the level of the otoliths could therefore be
detected using c/o VEMPs in MD patients. With
regards to the amplitude and latency values of
VEMPs, there are many factors that can affect these
values such as basic muscle activity, patient’s position,
and general conditions [22, 23]. Because of their non-
specific value in VEMPs testing, we used a qualitative
approach to VEMPs results. Our definition for abnor-
mal VEMP is an absence of VEMP response.
In our study, we found that patients with MD showed
higher rate of abnormal responses in c/oVEMPs by
stimulation on their affected side than the controls. The
incidence of abnormal response of o/cVEMP in our
study was 40 and 16.7 % respectively. The abnormal in-
cidence of cVEMPs is a little higher than the results re-
ported by Egami et al. [24], who studied 114 cases of
unilateral MD by cVEMPs and found that 34 (29.8 %)
showed abnormal click-VEMPs solely on the affected
side (decreased responses in 8 patients; absent responses
in 26 patients). In 2015, Salviza et al. [25] researched the
frequency-associated VEMP responds in MD diseases,
the incidence of no oVEMP responses to 500-Hz ACS
were 23 % in affected ears of patients with MD which
the abnormal incidence of oVEMPs is similar to our
result.
In cVEMPs testing, abnormalities were detected in
25 % of subjects in the ES MD group and in 70 % of
subjects in the LS MD group. There was a higher rate of
abnormality in the LS MD group, the difference between
the two groups was significant. This suggests that LS
MD patients may have more saccular damage result in
gradual increases with the aggravation of cochlear injury
in MD. In oVEMPs testing, abnormalities were detected
in 5 % of subjects in the ES MD group and in 40 % of
subjects in the LS MD group. Abnormal response rate
was significantly higher in LS MD patients than ES MD
patients. This suggests that LS MD patients may have
more utricular damage which also gradually increases
with the aggravation of cochlear injury in MD. In 2013,
Kim et al. [26] compared interaural amplitude difference
(IAD) ratio of VEMP with the MD staging system to
evaluate the clinical usefulness of VEMP in predicting
the disease stage. There was a tendency toward a de-
creasing response of VEMP, but this trend was not sta-
tistically significant. We used a qualitative approach
defining an absence of VEMP response as abnormal to
VEMPs results and verified the trend that otolith dam-
age is gradually increasing with the aggravation of coch-
lear injury in MD.
In our study, there was a higher rate of abnormal
cVEMP results than oVEMP results in MD patients.
These findings support the possibility that saccular func-
tion in MD patients is more heavily damaged than ut-
ricular function. Konishi et al. [27] observed that the
utriculo-endolymphatic (UE) valve opens for several days
after hydrops formation begins and then closes due to
the compression caused by increasing hydrops. The UE
valve exists at the junction between the utricle and ut-
ricular duct. The endolymph can easily flow in the direc-
tion from the utricular duct to the utricle but not in the
reverse direction thus concluding the role of the UE
valve is to maintain pressure in the utricle and semicir-
cular canals [28]. An acute pressure reduction in the sac-
cule can collapse the pars superior (saccule and cochlear
duct) but not the utricle, therefore endolymph pressure
in the utricle can be maintained independently of the
pressure in the pars superior [29]. Our findings of more
damage in saccule than utricule can also support this
theory found by Wen et al. [29].
VEMPs is a good method for evaluation of otolith
function; however this test requires specialized equip-
ment and complicated procedures for separate analyses
of utricular and saccular function as the VOR gain re-
duction is under the influence of both utricular and
Table 2 The abnormal c/oVEMP responses details in control




cVEMP oVEMP cVEMP oVEMP cVEMP oVEMP
Control(30) 2 1 28 29 6.67 % 3.34 %
ES-MD(20) 5 1 15 19 25 % 5 %
LS-MD(10) 7 4 3 6 70 % 40 %
MD(30) 12 5 18 25 40 % 16.7 %
MD Ménière’s disease, ES-MD early stage group in MD, LS-MD late stage group
in MD; In cVEMPs, MD VS Control: (p < 0.05), ES VS LS: (p < 0.05); In oVEMPs,
MD VS Control: (p < 0.05), ES VS LS: (p < 0.05); In MD, cVEMP VS
oVEMP: (p < 0.05)
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saccular dysfunction, in addition to semicircular canal-
otolith interaction. In the present study, abnormalities in
cVEMPs was frequently detected which is consistent
with the suggested underlying pathology of MD, namely
hydrops of the saccular prior to the utricular. Those ears
showing abnormal cVEMPs as well as oVEMPs might
have severe hydrops changes causing dysfunction of the
utricle and the saccule.
Considering the controversy in the stability and re-
peatability of c/oVEMPs, we defined abnormal c/
oVEMPs as absent responses in our study. As a result,
we did not analyse the latency and amplitude of the
waves in c/oVEMPs. The major limitation of our study
is the small number of MD patients. Another limitation
is the average age of our study subjects were under
60 years and the incidence of MD is higher in the elderly
resulting in a potential bias in the research. In future re-
search, a larger sample size will be obtained such that
quantitative analysis of otolith function in MD patients
can be performed.
Conclusion
An increased occurrence of abnormal c/oVEMP recordings
appeared in MD patients, possibly as a result of hydrop of
the otolith. cVEMPs were more often abnormal in MD pa-
tients as compared to oVEMPs, suggesting that saccular
dysfunction may be more common than utricular dysfunc-
tion. Furthermore, o/cVEMP abnormalities in the LS-MD
group were significantly higher than those in the ES-MD
group, suggesting the trend that otolith damage is gradually
increasing with the aggravation of cochlear injury in MD.
Abbreviations
c/oVEMPs, cervical and ocular vestibular evoked myogenic potentials; ES-MD,
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